SMAD7 and colorectal carcinoma: Moreover, in a study from Boulay and colleagues, Smad7 mutations were analyzed in 264 CRC biopsies, and amplification of Smad7 gene was associated with a poor prognosis, with a possible dose effect, while deletion of Smad7 gene associated with a better outcome (95).